TABLE 1

Pharmacokinetic and oral bioavailability data for MLi-2 in micea

Parameter2 mg/kg IV10 mg/kg PO
AUC (μM⋅h)0.664 (7%)1.50 (52%)
Cmax (μM)0.716 (11%)0.298 (72%)
Tmax (h)0.75 (58%)
MRT (h)2.7 (17%)11 (63%)
%F45 (52%)
  • AUC, area under the curve; Cmax, maximum observed drug concentration; Tmax, time to maximum observed drug concentration; MRT, mean residence time; %F, oral bioavailability.

  • a Values are presented as mean (CV%), N = 3.